Skip to main content

Take the fast track to becoming a V3 and V3+ expert

Learn More
DATACC BY DIME PROJECT

Building a digitally derived tool to prevent the relapse of OUD and combat the opioid epidemic

Opioid use disorder (OUD) is a public health epidemic – an estimated 5.7 million U.S. citizens and more than 40 million individuals worldwide suffer from OUD. In addition, the relapse rate is devastatingly high, leading to unacceptably high death rates.

The Digital Health Measurement Collaborative Community (DATAcc) by the Digital Medicine Society (DiMe) and a team of scientific and industry leaders are collaborating on work funded by FDA through the Triangle CERSI to inform the development of a scalable and person-focused risk prediction tool for opioid relapse.

Are you ready to get involved in this project?

Contact us

OUD project logo
Thank you for your interest in this work. Please fill out the form below and we will be in touch!
Name(Required)
This field is for validation purposes and should be left unchanged.

“Ownership in the hands of the person who might be struggling with opiate use so that they can be creating their own safety plan with a trusted individual that they choose [made possible by a relapse risk prediction tool]… I think that’s really beautiful.”

– QUOTE FROM A PERSON LIVING WITH OUD

Combating an epidemic with digital innovation

70% of patients with OUD report they would use a relapse prevention tool to empower them to manage their OUD treatment.

We are laying the groundwork for a game-changing relapse prevention tool that has the potential to save tens of thousands of lives worldwide.

→ See cards below for details

DiMe and the BIG IDEAs Lab at Duke University conducted in-depth research, including a systematic review, stakeholder interviews, and a nationwide survey, to shape the research design and methods for developing the tool. Now, we’re running a focused pilot to collect the best possible data to build an opioid relapse prevention tool.

We are leveraging consumer sensor-based digital health technologies (sDHT) and data processing algorithms to develop a first-of-its-kind, sensor-derived relapse prevention tool that flags when a person is likely at risk of relapse and might need support.

This work has the potential to save the 81,000 lives lost every year and represents a critical step toward ending the opioid epidemic. The new relapse prevention tool will ensure that those living with OUD are empowered with critical information relevant to their recovery and get the support they need, when they need it.

Conducting compelling research

DiMe and the BIG IDEAs Lab at Duke University conducted in-depth research, including a systematic review, stakeholder interviews, and a nationwide survey, to shape the research design and methods for developing the tool. Now, we’re running a focused pilot to collect the best possible data to build an opioid relapse prevention tool.

Building an opioid relapse prevention tool

We are leveraging consumer sensor-based digital health technologies (sDHT) and data processing algorithms to develop a first-of-its-kind, sensor-derived relapse prevention tool that flags when a person is likely at risk of relapse and might need support.

Saving lives globally

This work has the potential to save the 81,000 lives lost every year and represents a critical step toward ending the opioid epidemic. The new relapse prevention tool will ensure that those living with OUD are empowered with critical information relevant to their recovery and get the support they need, when they need it.

Our partners

DATAcc is thrilled to collaborate with an impressive team of scientific and industry leaders to conduct this critical work.

    Together, we are committed to saving lives and improving patient care by fearlessly tackling the opioid crisis.

    For individuals striving to regain their health and productivity as part of opioid addiction recovery, preventing relapses is essential… Our Triangle CERSI program serves as the ideal platform for this work, bringing together academia, industry, and the FDA to address high-priority regulatory needs and accelerate solutions.


    – Christin Daniels, Executive Director
    Triangle Center of Excellence in Regulatory Science and Innovation (Triangle CERSI)

    OUD is a complex challenge, and complex challenges require innovative collaboration and solutions. Our team is working to incorporate the many issues at play for those facing OUD and build a tool that can meaningfully change the arc of OUD relapse and save thousands of lives.

    –     Candice Taguibao, Associate Program Director
    DiMe

    Leveraging technological advancements to help develop evidence-based protocols for individuals living with OUD, as well as their families, loved ones, and care teams, will position these interventions for success. We’re proud to support this study by providing continuous health monitoring and personalized, data-driven insights.

    –     Shyamal Patel, Senior Vice President of Science
    ŌURA

    Digital tools give us a unique opportunity to detect early warning signs of events like OUD relapse and intervene before it happens. By harnessing continuous data from wearables and smartphones, we hope to be able to support people with OUD in real time, when and where they can benefit most.

    –     Jessilyn Dunn, Assistant Professor of Biomedical Engineering, Director
    BIG IDEAs Lab, Duke University

    Recovering from opioid use is not a solo journey, but requires an integrated system of personal, peer, and professional resources.

    –     Dr. Anthony Steele, Director of Medical Services
    Alcohol and Drug Services (ADS)

    Partnering with DiMe aligns with our mission to improve clinical trials through digital innovation. Together, we’re bringing digital solutions to the forefront of clinical research, creating streamlined, patient-centered experiences and empowering all participants with advanced tools and support.

    –     Chris Venezia, CEO
    ProofPilot

    Morse Clinics is excited to partner on this pilot to continue making strides to help individuals who experience opioid use disorder!

    –     Samantha Burggraf, Opioid Treatment Program Director
    Morse Clinic of Zebulon

      For individuals striving to regain their health and productivity as part of opioid addiction recovery, preventing relapses is essential… Our Triangle CERSI program serves as the ideal platform for this work, bringing together academia, industry, and the FDA to address high-priority regulatory needs and accelerate solutions.


      – Christin Daniels, Executive Director
      Triangle Center of Excellence in Regulatory Science and Innovation (Triangle CERSI)

      OUD is a complex challenge, and complex challenges require innovative collaboration and solutions. Our team is working to incorporate the many issues at play for those facing OUD and build a tool that can meaningfully change the arc of OUD relapse and save thousands of lives.

      –       Candice Taguibao, Associate Program Director
      DiMe

      Leveraging technological advancements to help develop evidence-based protocols for individuals living with OUD, as well as their families, loved ones, and care teams, will position these interventions for success. We’re proud to support this study by providing continuous health monitoring and personalized, data-driven insights.

      –       Shyamal Patel, Senior Vice President of Science
      ŌURA

      Digital tools give us a unique opportunity to detect early warning signs of events like OUD relapse and intervene before it happens. By harnessing continuous data from wearables and smartphones, we hope to be able to support people with OUD in real time, when and where they can benefit most.

      –       Jessilyn Dunn, Assistant Professor of Biomedical Engineering, Director
      BIG IDEAs Lab, Duke University

      Recovering from opioid use is not a solo journey, but requires an integrated system of personal, peer, and professional resources.

      –       Dr. Anthony Steele, Director of Medical Services
      Alcohol and Drug Services (ADS)

      Partnering with DiMe aligns with our mission to improve clinical trials through digital innovation. Together, we’re bringing digital solutions to the forefront of clinical research, creating streamlined, patient-centered experiences and empowering all participants with advanced tools and support.

      –       Chris Venezia, CEO
      ProofPilot

      Morse Clinics is excited to partner on this pilot to continue making strides to help individuals who experience opioid use disorder!

      –       Samantha Burggraf, Opioid Treatment Program Director
      Morse Clinic of Zebulon